Literature DB >> 10494273

Ways to minimize adverse drug reactions. Individualized doses and common sense are key.

J S Cohen1.   

Abstract

The great majority of adverse drug reactions are dose-related and occur in patients taking standard doses of medications. These facts suggest that for many patients, standard drug doses may be excessive. The principle of variability among individuals, which requires tailoring the dose to the patient, needs to be reasserted in clinical medicine to reduce the incidence of side effects. Physicians should obtain patients' histories of drug reactions and have at hand information on the full range of effective drug doses, including data on low doses gathered in prerelease and postrelease drug studies. Whenever possible, manufacturers should provide a range of doses and breakable tablets to facilitate flexible dosing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10494273     DOI: 10.3810/pgm.1999.09.688

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  9 in total

1.  The frequency of inappropriate tablet splitting in primary care.

Authors:  R Quinzler; C Gasse; A Schneider; P Kaufmann-Kolle; J Szecsenyi; W E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2006-10-06       Impact factor: 2.953

Review 2.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.

Authors:  Mohamed A Alhnan; Tochukwu C Okwuosa; Muzna Sadia; Ka-Wai Wan; Waqar Ahmed; Basel Arafat
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

3.  Hot melt extrusion paired fused deposition modeling 3D printing to develop hydroxypropyl cellulose based floating tablets of cinnarizine.

Authors:  Anh Q Vo; Jiaxiang Zhang; Dinesh Nyavanandi; Suresh Bandari; Michael A Repka
Journal:  Carbohydr Polym       Date:  2020-06-04       Impact factor: 9.381

4.  Implementation and evaluation of adverse drug reaction monitoring system in a tertiary care teaching hospital in Mumbai, India.

Authors:  Dindayal Patidar; Mithun S Rajput; Nilesh P Nirmal; Wenny Savitri
Journal:  Interdiscip Toxicol       Date:  2013-03

5.  3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.

Authors:  Heidi Öblom; Jiaxiang Zhang; Manjeet Pimparade; Isabell Speer; Maren Preis; Michael Repka; Niklas Sandler
Journal:  AAPS PharmSciTech       Date:  2019-01-07       Impact factor: 3.246

Review 6.  Practicality of 3D Printed Personalized Medicines in Therapeutics.

Authors:  Hilda Amekyeh; Faris Tarlochan; Nashiru Billa
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

Review 7.  Metamorphosis of Twin Screw Extruder-Based Granulation Technology: Applications Focusing on Its Impact on Conventional Granulation Technology.

Authors:  Rajat Radhakrishna Rao; Abhijeet Pandey; Aswathi R Hegde; Vijay Induvadan Kulkarni; Chetan Chincholi; Vinay Rao; Indu Bhushan; Srinivas Mutalik
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 3.246

8.  D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine.

Authors:  Stéphane Roulon; Ian Soulairol; Maxime Cazes; Léna Lemierre; Nicolas Payre; Laurent Delbreilh; Jean Alié
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

9.  A 3D-Printed Polymer-Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations.

Authors:  Bryce W Barber; Camille Dumont; Philippe Caisse; George P Simon; Ben J Boyd
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.